Christian Steidl

Christian Steidl

UNVERIFIED PROFILE

Are you Christian Steidl?   Register this Author

Register author
Christian Steidl

Christian Steidl

Publications by authors named "Christian Steidl"

Are you Christian Steidl?   Register this Author

100Publications

2971Reads

7Profile Views

Ultrasensitive Detection of NOTCH1 c.7544_7545delCT Mutations in Chronic Lymphocytic Leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts Clinical Outcome in Cases with Trisomy 12.

J Mol Diagn 2020 Feb 6. Epub 2020 Feb 6.

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2020.01.008DOI Listing
February 2020

Novel Biomarker Approaches in Classic Hodgkin Lymphoma.

Cancer J 2018 Sep/Oct;24(5):206-214

From the Department for Lymphoid Cancer Research, BC Cancer Research Centre; and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000334DOI Listing
July 2019

Identification of TRA-1-60-positive cells as a potent refractory population in follicular lymphomas.

Cancer Sci 2019 Jan 8;110(1):443-457. Epub 2018 Dec 8.

Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13870DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317956PMC
January 2019

The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.

Blood Rev 2018 05 20;32(3):249-255. Epub 2017 Dec 20.

Department of Lymphoid Cancer Research, BC Cancer Agency, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0268960X173006
Publisher Site
http://dx.doi.org/10.1016/j.blre.2017.12.001DOI Listing
May 2018

Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.

J Pathol 2018 04 6;244(5):598-609. Epub 2018 Mar 6.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5043DOI Listing
April 2018

Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies.

Blood 2018 04 2;131(15):1654-1665. Epub 2018 Mar 2.

Department for Lymphoid Cancer Research, British Columbia Cancer Agency, Vancouver, BC, Canada; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-09-772632DOI Listing
April 2018

Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.

J Mol Diagn 2018 03 8;20(2):203-214. Epub 2018 Feb 8.

Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.11.010DOI Listing
March 2018

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.

J Clin Oncol 2017 Nov 12;35(32):3722-3733. Epub 2017 Sep 12.

Fong Chun Chan, Anja Mottok, Alina S. Gerrie, Maryse Power, Kerry J. Savage, Sohrab P. Shah, Joseph M. Connors, Randy D. Gascoyne, David W. Scott, and Christian Steidl, British Columbia Cancer Agency; Fong Chun Chan, Anja Mottok, Sohrab P. Shah, and Christian Steidl, University of British Columbia, Canada; Marcel Nijland, Arjan Diepstra, and Anke van den Berg, University Medical Center Groningen, Groningen, the Netherlands; and Peter Kamper, Francesco d'Amore, Alexander Lindholm d'Amore, and Stephen Hamilton-Dutoit, Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7925DOI Listing
November 2017

The ecosystem of classical Hodgkin lymphoma.

Authors:
Christian Steidl

Blood 2017 11;130(22):2360-2361

BRITISH COLUMBIA CANCER AGENCY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-10-807172DOI Listing
November 2017

Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.

J Pathol 2017 10 5;243(2):220-229. Epub 2017 Sep 5.

Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605421PMC
October 2017

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.

J Clin Oncol 2017 May 14;35(15):1668-1677. Epub 2017 Mar 14.

David W. Scott, Pau Abrisqueta, Graham W. Slack, Anja Mottok, Diego Villa, Merrill Boyle, Fong Chun Chan, Christian Steidl, Joseph M. Connors, and Randy D. Gascoyne, BC Cancer Agency; Anja Mottok, Christian Steidl, and Randy D. Gascoyne, University of British Columbia, Vancouver, British Columbia; Jan Delabie, University of Toronto, Toronto, Ontario, Canada; Pau Abrisqueta, Vall d'Hebron University Hospital; Pedro Jares, Cristina Royo, Guillem Clot, Magda Pinyol, and Elias Campo, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; George W. Wright, Elaine S. Jaffe, and Louis M. Staudt, National Institutes of Health, Bethesda, MD; Hilka Rauert-Wunderlich and Andreas Rosenwald, University of Würzburg, Würzburg; German Ott, Robert Bosch Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Rita M. Braziel, Oregon Health & Sciences University, Portland, OR; Wing C. Chan and Dennis D. Weisenburger, City of Hope, Duarte, CA; James R. Cook, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH; Timothy C. Greiner and Kai Fu, University of Nebraska Medical Center, Omaha, NE; Erlend B. Smeland and Harald Holte, Oslo University Hospital, Oslo, Norway; and Lisa M. Rimsza, Mayo Clinic, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455765PMC
May 2017

Defining the clonality of peripheral T cell lymphomas using RNA-seq.

Bioinformatics 2017 04;33(8):1111-1115

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btw810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408843PMC
April 2017

Exposing Hodgkin-Reed-Sternberg cells.

Authors:
Christian Steidl

Blood 2017 01;129(1):6-7

BRITISH COLUMBIA CANCER AGENCY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-11-746701DOI Listing
January 2017

Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them.

Expert Rev Hematol 2016 11 17;9(11):1007-1009. Epub 2016 Oct 17.

a Centre for Lymphoid Cancer , British Columbia Cancer Agency , British Columbia , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1242404DOI Listing
November 2016

Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.

Blood 2016 09 7;128(9):1206-13. Epub 2016 Jun 7.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-11-683003DOI Listing
September 2016

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.

Blood 2016 05 1;127(18):2182-8. Epub 2016 Feb 1.

Department of Pathology and Laboratory Medicine, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-676700DOI Listing
May 2016

Structural genomic alterations in primary mediastinal large B-cell lymphoma.

Leuk Lymphoma 2015 21;56(8):2239-50. Epub 2015 Jan 21.

a Department of Lymphoid Cancer Research , BC Cancer Research Centre , Vancouver , BC , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.985673DOI Listing
April 2016

Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression.

Cell Rep 2015 Nov 5;13(7):1418-1431. Epub 2015 Nov 5.

Centre for Lymphoid Cancer, Department of Lymphoid Cancer Research, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.10.008DOI Listing
November 2015

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.

Am J Surg Pathol 2015 Oct;39(10):1322-30

*Department of Pathology and Microbiology ¶Department of Biostatistics, College of Public Health ##Department of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE †Metabolism Branch **Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, MD ∥Department of Pathology, City of Hope National Medical Center, Duarte, CA #Department of Pathology, University of Arizona, Tucson, AZ §§Department of Clinical Pathology, Oregon Health and Science University, Portland, OR ∥∥Department of Molecular Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH ‡Institute of Pathology, Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg ¶¶Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany §British Columbia Cancer Agency, Centre for Lymphoid Cancer, University of British Columbia, Vancouver, BC, Canada ††Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain ‡‡Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000473DOI Listing
October 2015

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.

J Clin Oncol 2015 Sep 3;33(26):2848-56. Epub 2015 Aug 3.

David W. Scott, Anja Mottok, Daisuke Ennishi, Pedro Farinha, Susana Ben-Neriah, Robert Kridel, Garrett S. Barry, Christoffer Hother, Pau Abrisqueta, Merrill Boyle, Barbara Meissner, Adele Telenius, Kerry J. Savage, Laurie H. Sehn, Graham W. Slack, Christian Steidl, Joseph M. Connors, and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; George W. Wright and Louis M. Staudt, National Cancer Institute, Bethesda, MD; and Lisa M. Rimsza, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554747PMC
September 2015

A two-pronged attack against mantle cell lymphoma.

Authors:
Christian Steidl

Blood 2015 Sep;126(13):1521-3

BRITISH COLUMBIA CANCER AGENCY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-08-662106DOI Listing
September 2015

Genomic alterations underlying immune privilege in malignant lymphomas.

Curr Opin Hematol 2015 Jul;22(4):343-54

aCentre for Lymphoid Cancer, BC Cancer Agency bDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000155DOI Listing
July 2015

Emerging biological insights and novel treatment strategies in primary mediastinal large B-cell lymphoma.

Semin Hematol 2015 Apr 17;52(2):119-25. Epub 2015 Jan 17.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00371963150000
Publisher Site
http://dx.doi.org/10.1053/j.seminhematol.2015.01.002DOI Listing
April 2015

Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

Blood 2015 Feb 2;125(6):999-1005. Epub 2014 Dec 2.

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada; Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-602714DOI Listing
February 2015

Tumor-associated macrophages in diffuse large B-cell lymphoma.

Haematologica 2015 Feb;100(2):143-5

Department of Lymphoid Cancer Research, BC Cancer Agency and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.124008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803134PMC
February 2015

CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.

Br J Haematol 2014 Dec 19;167(5):608-17. Epub 2014 Aug 19.

Centre for Lymphoid Cancers, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13085DOI Listing
December 2014

The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):144-50. Epub 2014 Nov 18.

Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.144DOI Listing
December 2014

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

Nat Genet 2014 Apr 16;46(4):329-35. Epub 2014 Feb 16.

1] Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2900DOI Listing
April 2014

New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.

Clin Cancer Res 2013 Jun 27;19(11):2797-803. Epub 2013 Feb 27.

Department of Medicine, New York University School of Medicine, NYU Cancer Institute, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928836PMC
June 2013

Lymphotoxin network pathways shape the tumor microenvironment.

Curr Opin Immunol 2013 Apr 20;25(2):222-9. Epub 2013 Jan 20.

Infectious and Inflammatory Diseases Center, Sanford Burnham Medical Research Institute, 10901N. Torrey Pines Road, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2013.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646954PMC
April 2013

The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.

Blood 2013 Apr 13;121(16):3161-4. Epub 2013 Feb 13.

Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada V5Z 1L3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-01-478834DOI Listing
April 2013

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.

Blood 2012 Apr 17;119(15):3503-11. Epub 2012 Feb 17.

Institute of Physiological Chemistry, University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-09-381905DOI Listing
April 2012

The molecular pathogenesis of primary mediastinal large B-cell lymphoma.

Blood 2011 Sep 23;118(10):2659-69. Epub 2011 Jun 23.

Department of Pathology and Experimental Therapeutics, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-05-32
Publisher Site
http://dx.doi.org/10.1182/blood-2011-05-326538DOI Listing
September 2011

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.

J Pathol 2011 Jul 18;224(3):328-33. Epub 2011 May 18.

The Center for Translational and Applied Genomics (CTAG) at the British Columbia (BC) Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2911DOI Listing
July 2011

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.

J Clin Oncol 2011 May 11;29(14):1812-26. Epub 2011 Apr 11.

Department of Pathology and Experimental Therapeutics, British Columbia Cancer Agency, 675 West 10th Ave, Room 5-113, Vancouver, BC V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.8401DOI Listing
May 2011

Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.

Blood 2010 Jul 25;116(3):418-27. Epub 2010 Mar 25.

Department of Pathology and Laboratory Medicine, Centre for Translational and Applied Genomics, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-12-257345DOI Listing
July 2010

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).

Mol Cancer 2010 Jan 26;9:14. Epub 2010 Jan 26.

Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Provincial Health Services Authority Laboratories, 600 West 10th Avenue, Vancouver, British Columbia, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-9-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829491PMC
January 2010